DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

SCWorx Corp.

OTCPK:WORX Stock Report

Market Cap: US$241.5k

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

SCWorx Past Earnings Performance

Past criteria checks 0/6

SCWorx's earnings have been declining at an average annual rate of -0.6%, while the Healthcare Services industry saw earnings growing at 21.8% annually. Revenues have been declining at an average rate of 12.3% per year.

Key information

-0.56%

Earnings growth rate

86.57%

EPS growth rate

Healthcare Services Industry Growth1.72%
Revenue growth rate-12.31%
Return on equity-33.99%
Net Margin-80.54%
Last Earnings Update30 Jun 2026

Recent past performance updates

Recent updates

Seeking Alpha • Aug 30

SCWorx renews, expands data service agreement with 500+ bed hospital in New England

SCWorx (NASDAQ:WORX) on Tuesday said it had renewed and expanded a data service agreement with an existing 500+ bed hospital in New England. WORX and the hospital had previously entered into a 1 year, $125K agreement. The new agreement is for 4 years at $200K per year. WORX did not name or identify the hospital. WORX said the new agreement included currently provided services as well as extended services. WORX stock +1.6% to $0.66 in afternoon trading.
Seeking Alpha • Jul 05

SCWorx climbs 10% on $5M stock buyback agreement

SCWorx (NASDAQ:WORX) entered stock purchase agreement with an institutional investor. Company will have the right, but not the obligation, to issue and sell to the investor up to $5M of common stock from time-to-time over the ~24-month term of the purchase agreement. Tim Hannibal, President & CEO commented, “We believe this commitment from the Institutional Investor demonstrates investor confidence in SCWorx, including our business model that leverages the SCWorx data management SaaS solution to assist hospitals in achieving their supply chain goals and cost savings objectives.” Company currently has a market cap of $7.9M.

Revenue & Expenses Breakdown

How SCWorx makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:WORX Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 263-220
31 Mar 263-420
31 Dec 253-420
30 Sep 253-420
30 Jun 253-320
31 Mar 253-120
31 Dec 243-120
30 Sep 243-420
30 Jun 243-420
31 Mar 244-420
31 Dec 234-430
30 Sep 234-230
30 Jun 234-130
31 Mar 234-230
31 Dec 224-240
30 Sep 224-240
30 Jun 224-350
31 Mar 225-460
31 Dec 215-460
30 Sep 215-350
30 Jun 215-460
31 Mar 215-780
31 Dec 205-780
30 Sep 205-10100
30 Jun 206-890
31 Mar 205-780
31 Dec 196-11130
30 Sep 195-9110
30 Jun 194-890
31 Mar 194-670
31 Dec 183010
30 Sep 18300-1
31 Dec 173000
31 Dec 162011

Quality Earnings: WORX is currently unprofitable.

Growing Profit Margin: WORX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: WORX is unprofitable, and losses have increased over the past 5 years at a rate of 0.6% per year.

Accelerating Growth: Unable to compare WORX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: WORX is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (14.8%).


Return on Equity

High ROE: WORX has a negative Return on Equity (-33.99%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/17 21:54
End of Day Share Price 2026/09/17 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

SCWorx Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide